Status:
COMPLETED
Special Survey for Paediatric Subjects
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Up to 15 years
Brief Summary
This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using NovoRapid® (insulin aspart) in children with type 1 and type 2 diabetes under normal clinical ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Requiring insulin therapy
- No treatment history of NovoRapid® (insulin aspart)
Exclusion
Key Trial Info
Start Date :
April 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
241 Patients enrolled
Trial Details
Trial ID
NCT01487382
Start Date
April 1 2002
End Date
October 1 2009
Last Update
March 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo, Japan, 1000005